SUMMARY Valproate is an important anticonvulsant which is rarely associated with fatal hepatotoxicity. Previous experiments have shown that valproate inhibits several metabolic processes in isolated rat hepatocytes and when administered to starved rats causes a fall in the blood concentrations of glucose and ketone bodies. Since these changes may be related to the hepatotoxicity, the effect of valproate administration on intermediary metabolism in man was studied. One gram of valproate given orally to fasted normal humans caused a 78% fall in the concentration of 3-hydroxybutyrate and a 60% fall in total ketones. Also the concentrations of lactate, pyruvate, alanine and glycerol increased after valproate administration. Similar changes were observed after intravenous administration of 400mg of valproate. Valproate clearly has a significant effect on intermediary metabolism in the liver and this is probably related to the mechanism of the hepatotoxicity. 
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Results
Oral administration
The mean peak serum valproate concentration, after oral administration of 1 0 g of sodium valproate, was 80jug/ml which is within the suggested therapeutic range of 50-100 pg/ml " (fig 1) . Blood glucose concentration fell by 17% over the 8 hours of the study, and the rate of fall did not appear to be affected by valproate administration (fig 2) . Concentrations of lactate, pyruvate and alanine rose initially and then declined (fig2). The concentration of glycerol was markedly increased by administration of valproate. Serum insulin remained at basal concentrations throughout the study. The most marked effect of valproate administration was on the blood concentration of ketone bodies (fig 3) . There was a 78% fall in the concentration of 3-hydroxybutyrate, a 38% fall in acetoacetate concentration and a 60% fall in total ketone body concentrations. There was also a 65% fall in the 3-hydroxybutyrate/acetoacetate ratio. These effects on blood ketones were greatest 90 minutes after the administration of valproate but were still evident 6 hours later.
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Intravenous administration
The subjects were fasted for longer (36 had been taking other anticonvulsants in addition to valproate. 14 Concentrations of valproate found in man during therapy inhibit fatty acid oxidation, fatty acid synthesis, pyruvate oxidation, urea synthesis and gluconeogenesis in isolated rat hepatocytes.34 All the metabolic disturbances caused by valproate can be explained by the increased acyl-CoA/CoASH ratio within the mitochondrial matrix due to the formation of valproyl-CoA by acyl-CoA synthetase in this compartment.3 These results prompted this investigation into the effect of valproate on intermediary metabolism in humans. Administration of valproate to normal fasted humans caused a marked lowering of blood ketone body concentrations. Ketone bodies are the major products of hepatic #-oxidation. Whilst falls in ketone body concentration may be partly due to increased utilisation in peripheral tissues, it is most likely that this indicates inhibition of fatty acid oxidation by valproate in human liver. Our results agree with those recently published by Thurston et al.7 These authors studied the effect of chronic valproate administration on blood metabolite concentrations in epileptic children and found a 67% decrease in the concentration of 3-hydroxybutyrate after an overnight fast. The metabolic response to fasting in control subjects has been extensively studied using the same laboratory techniques."5 The changes in metabolite concentrations in blood during fasting are gradual and not associated with marked fluctuations as seen after valproate administration. Johnston et al15 found that blood glucose concentrations fell by 18% and alanine concentratiorns by 40% over a period of fasting from 12 to 60 hours although the concentrations of blood lactate and pyruvate did not change. Blood glycerol and ketone bodies and the plasma concentration of NEFA rose steadily. The 
